Epidemiological and clinicopathological features of lung cancer in Algeria

Author:

Lahmadi Mohamed1,Beddar Leila2,Ketit Souad2,Filali Taha3,Djemaa Aicha3,Satta Dalila4

Affiliation:

1. Division of Biotechnology and Health, Biotechnology Research Centre (CRBt), Constantine

2. Department of Anatomical Pathology, Benbadis University Hospital, Constantine

3. Department of Medical Oncology, Benbadis University Hospital, Constantine

4. Department of Animal Biology, University of Mentouri Brothers Constantine 1, Constantine

Abstract

Abstract Purpose: Lung cancer is the most commonly diagnosed cancer in men and the leading cause of cancer-related death in Algeria. We investigated the clinicopathological characteristics of a group of patients with lung cancer in Eastern Algeria, that might reflect a national landscape. Methods: This retrospective study was performed on 173 histologically proven cases of lung cancer at Benbadis university hospital of Constantine from January 2015 to February 2021. Clinical and pathological variables were investigated based on the available data found in the patient's medical records. Results: Lung cancer showed a male predominance with a sex ratio of 6.5. Majority of our patients (86%) aged greater than 50 years with a median age of 61 years. Histologically, adenocarcinoma was found in over 56.6% of the cases, followed by squamous cell carcinoma with 22.5%, whereas 12.8% were non-NSCLC subtypes. Tobacco smoking was estimated at 79.1% in men. Non-smokers represented over 32.5% of patients, of which 45.1% were female. Most of our patients (79%) have an advanced stage at diagnosis, including 57.3% with metastatic disease. Around 60% of patients underwent chemotherapy, of which 81% was first-line treatment, with a median diagnostic delay of almost 4 months. Conclusion: Lung cancer presents at an early age and advanced stage in Algerian patients. Smoking remains the most important risk factor in men and adenocarcinoma is the predominant histological subtype. Thus, primary prevention, based on tobacco control and screening programs, and access to novel therapies may be the best strategies to reduce lung cancer morbidity and mortality.

Publisher

Research Square Platform LLC

Reference40 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA;Sung H;Cancer J Clin,2021

2. World Health Organization International, Agency for Research on Cancer. GLOBOCAN 2020: estimated cancer incidence, mortality, and prevalence worldwide in 2020. http://globocan.iarc.fr/Pages/fact_sheets_cancer

3. The international epidemiology of lung cancer: Latest trends, disparities, and tumor characteristics;Cheng T;J Thorac Oncol,2016

4. Barta JA, Powell CA, Wisnivesky JP (2019) Global epidemiology of lung cancer. Ann Glob Health. 22;85(1):8. https://doi.org/10.5334/aogh.2419

5. The effect of advances in lung-cancer treatment on population mortality;Howlader N;N Engl J Med,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3